When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KDMN - Kadmon's KD025 successful in pivotal cGvHD study; shares up 17% after hours
Kadmon Holdings Inc.
A pivotal Phase 2 study evaluating Kadmon Holdings' (NYSE:KDMN) lead candidate KD025 in patients with chronic graft-vs-host disease (cGvHD) who had received at least two prior lines of therapy met the primary endpoint at the interim analysis, two months after the completion of enrollment.
More news on: Kadmon Holdings, Inc., Healthcare stocks news, Stocks on the move,